Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karim Bennaceur

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Geroscience|April 22, 2023
Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarctionBilal Bawamia, Luke Spray, Vincent K Wangsaputra, et al.
Frontiers in Immunology|May 28, 2021
The Fractalkine Receptor CX<sub>3</sub>CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular RemodelingLuke Spray, Catherine Park, Suzanne Cormack, et al.
Oncotarget|June 22, 2016
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiationCatherine J Drummond, Arman Esfandiari, Junfeng Liu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 7, 2012
Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?David Kavanagh, Isabel Y Pappworth, Holly Anderson, et al.
Molecular Immunology|August 25, 2014
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)Rachael Watson, Emma Wearmouth, Amy-Claire McLoughlin, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2011
MDM2-p53 protein-protein interaction inhibitors: a-ring substituted isoindolinonesAnna F Watson, Junfeng Liu, Karim Bennaceur, et al.
Frontiers in Immunology|July 10, 2023
Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarctionKateryna Sopova, Simon Tual-Chalot, Matthias Mueller-Hennessen, et al.
Journal of Medicinal Chemistry|February 15, 2011
Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potencyIan R Hardcastle, Junfeng Liu, Eric Valeur, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Geroscience|April 22, 2023
Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarctionBilal Bawamia, Luke Spray, Vincent K Wangsaputra, et al.
Frontiers in Immunology|May 28, 2021
The Fractalkine Receptor CX<sub>3</sub>CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular RemodelingLuke Spray, Catherine Park, Suzanne Cormack, et al.
Oncotarget|June 22, 2016
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiationCatherine J Drummond, Arman Esfandiari, Junfeng Liu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 7, 2012
Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?David Kavanagh, Isabel Y Pappworth, Holly Anderson, et al.
Molecular Immunology|August 25, 2014
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)Rachael Watson, Emma Wearmouth, Amy-Claire McLoughlin, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2011
MDM2-p53 protein-protein interaction inhibitors: a-ring substituted isoindolinonesAnna F Watson, Junfeng Liu, Karim Bennaceur, et al.
Frontiers in Immunology|July 10, 2023
Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarctionKateryna Sopova, Simon Tual-Chalot, Matthias Mueller-Hennessen, et al.
Journal of Medicinal Chemistry|February 15, 2011
Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potencyIan R Hardcastle, Junfeng Liu, Eric Valeur, et al.
Pageof 2